Finley John David bought PALI
February 11, 2026 · Form 4 insider transaction
Finley John David bought 13,333 shares of Palisade Bio, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
13,333
Price
N/A
Total value
N/A
InsiderFinley John David
Role—
CompanyPalisade Bio, Inc. (PALI)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateFebruary 11, 2026
Filing dateFebruary 13, 2026
Shares owned after31,249
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs") granted on February 11, 2025.; Includes 4,444 shares acquired under the Issuer's Employee Stock Purchase Plan on November 20, 2025.